These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7563911)

  • 1. [HCV-RNA quantity of the serum].
    Sasaki Y; Hige S; Nagasaka A; Matsushima T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
    [No Abstract]   [Full Text] [Related]  

  • 2. [HCV-RNA of the hepatocytes of the complete responders with disappearance serum HCV-RNA after IFN treatment--using in situ hybridization].
    Terada M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):944-8. PubMed ID: 7563906
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 5. [HCV-RNA in liver of chronic hepatitis C--plus strand RNA and minus strand RNA].
    Endo H; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):623-8. PubMed ID: 7563844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intercalation monitoring PCR(IM-PCR), its principle and application: quantitative monitoring of HCV RNA in the course of IFN therapy].
    Ishiguro T; Saitoh J
    Rinsho Byori; 1997 Mar; 45(3):213-7. PubMed ID: 9086823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
    Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis C infection: unraveling the mystery.
    Monsour HP
    Am J Gastroenterol; 1994 Sep; 89(9):1424-6. PubMed ID: 7521571
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?
    Shire N; Koziel MJ
    Clin Infect Dis; 2004 Dec; 39(12):1761-3. PubMed ID: 15578396
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prediction of interferon therapy outcome by PCR-SSCP analysis of HCV 5' NCR].
    Kurihara C; Katayama K; Fukushi S; Hoshino FB; Ando T; Oya A; Ishiyama N
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):326-32. PubMed ID: 7563742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C].
    Baba T; Makino R; Shibata M; Harada E; Mitamura K
    Nihon Rinsho; 1997 Mar; 55(3):625-30. PubMed ID: 9086771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin: Reappearance of references published in 2005-2009.
    Gelderblom HC; Beld MG
    J Clin Virol; 2010 Jun; 48(2):150-1; author reply 152. PubMed ID: 20347385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
    Buti M
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
    Fytili P; Tiemann C; Wang C; Schulz S; Schaffer S; Manns MP; Wedemeyer H
    J Clin Virol; 2007 Aug; 39(4):308-11. PubMed ID: 17625963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of hepatitis C virus RNA from serum in HIV/hepatitis C virus coinfection indicates eradication from peripheral blood mononuclear cells.
    Page EE; Cox A; Atkins M; Nelson MR
    AIDS; 2010 Jun; 24(9):1267-71. PubMed ID: 20386424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus infection and cardiomyopathy].
    Matsumori A
    Nihon Rinsho; 1999 Feb; 57(2):455-63. PubMed ID: 10078023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.